POU3F1
POU domain, class 3, transcription factor 1 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||
Symbols | POU3F1 ; OCT6; OTF6; SCIP | ||||||||||
External IDs | Template:OMIM5 Template:MGI HomoloGene: 20590 | ||||||||||
| |||||||||||
RNA expression pattern | |||||||||||
File:PBB GE POU3F1 208345 s at tn.png | |||||||||||
File:PBB GE POU3F1 210475 at tn.png | |||||||||||
More reference expression data | |||||||||||
Orthologs | |||||||||||
Template:GNF Ortholog box | |||||||||||
Species | Human | Mouse | |||||||||
Entrez | n/a | n/a | |||||||||
Ensembl | n/a | n/a | |||||||||
UniProt | n/a | n/a | |||||||||
RefSeq (mRNA) | n/a | n/a | |||||||||
RefSeq (protein) | n/a | n/a | |||||||||
Location (UCSC) | n/a | n/a | |||||||||
PubMed search | n/a | n/a |
POU domain, class 3, transcription factor 1, also known as POU3F1, is a human gene.[1]
See also
References
Further reading
- Monuki ES, Kuhn R, Weinmaster G; et al. (1990). "Expression and activity of the POU transcription factor SCIP". Science. 249 (4974): 1300–3. PMID 1975954.
- Suzuki N, Rohdewohld H, Neuman T; et al. (1990). "Oct-6: a POU transcription factor expressed in embryonal stem cells and in the developing brain". EMBO J. 9 (11): 3723–32. PMID 1976514.
- Zwilling S, König H, Wirth T (1995). "High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors". EMBO J. 14 (6): 1198–208. PMID 7720710.
- Leger H, Sock E, Renner K; et al. (1995). "Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y". Mol. Cell. Biol. 15 (7): 3738–47. PMID 7791781.
- Faus I, Hsu HJ, Fuchs E (1994). "Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia". Mol. Cell. Biol. 14 (5): 3263–75. PMID 7909356.
- Tobler A, Schreiber E, Fontana A (1993). "The human Oct-6 POU transcription factor lacks the first 50 amino acids of its murine counterpart". Nucleic Acids Res. 21 (4): 1043. PMID 8451175.
- Abdel-Rahman B, Fiddler M, Rappolee D, Pergament E (1996). "Expression of transcription regulating genes in human preimplantation embryos". Hum. Reprod. 10 (10): 2787–92. PMID 8567814.
- Jaegle M, Mandemakers W, Broos L; et al. (1996). "The POU factor Oct-6 and Schwann cell differentiation". Science. 273 (5274): 507–10. PMID 8662541.
- Sock E, Enderich J, Rosenfeld MG, Wegner M (1996). "Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6". J. Biol. Chem. 271 (29): 17512–8. PMID 8663425.
- Malik KF, Jaffe H, Brady J, Young WS (1997). "The class III POU factor Brn-4 interacts with other class III POU factors and the heterogeneous nuclear ribonucleoprotein U.". Brain Res. Mol. Brain Res. 45 (1): 99–107. PMID 9105675.
- Sumiyama K, Washio-Watanabe K, Ono T; et al. (1998). "Human class III POU genes, POU3F1 and POU3F3, map to chromosomes 1p34.1 and 3p14.2". Mamm. Genome. 9 (2): 180–1. PMID 9457692.
- Arroyo EJ, Bermingham JR, Rosenfeld MG, Scherer SS (1998). "Promyelinating Schwann cells express Tst-1/SCIP/Oct-6". J. Neurosci. 18 (19): 7891–902. PMID 9742157.
- Kawasaki T, Oka N, Tachibana H; et al. (2003). "Oct6, a transcription factor controlling myelination, is a marker for active nerve regeneration in peripheral neuropathies". Acta Neuropathol. 105 (3): 203–8. doi:10.1007/s00401-002-0630-9. PMID 12557005.
- Beck IM, Müller M, Mentlein R; et al. (2007). "Matrix metalloproteinase-19 expression in keratinocytes is repressed by transcription factors Tst-1 and Skn-1a: implications for keratinocyte differentiation". J. Invest. Dermatol. 127 (5): 1107–14. doi:10.1038/sj.jid.5700674. PMID 17195013.
- Ryu EJ, Wang JY, Le N; et al. (2007). "Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss". J. Neurosci. 27 (43): 11552–9. doi:10.1523/JNEUROSCI.5497-06.2007. PMID 17959798.
External links
- POU3F1+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)
This protein-related article is a stub. You can help Wikipedia by expanding it. |
This article incorporates text from the United States National Library of Medicine, which is in the public domain.